Ep. 109 - What's Next for Novartis? Plus: AACR, Merck KGaA
BioCentury This Week
00:00
How Does a Pd One Inhibiter Work?
E c r x is trying to up end the price in paradise of drugs. The last week, fda advisers found ameli's data to be be the limits of flexibility. We'll have senior editor carntocotch tusman on the pod next week to give you her high lights. And of course, she'll be telling you all about our new distillery dash board.
Transcript
Play full episode
